1Trune DR, Kempton JB, Mitchell C. Decreased auditory function in the C3H/lpr autoimmune disease mouse. Hear Res. 1996; 95: 57-62.
2Trune DR. Cochlear immunoglobulin in the C3H/lpr mouse model for autoimmune hearing loss. Otolaryngol Head Neck Surg. 1997; 117:504-508.
3Lin DW, Trune DR. Breakdown of stria vascularis blood-labyrinth barrier in C3H/lpr autoimmune disease mice. Otolaryngol Head Neck Surg. 1997; 117: 530-534.
4Ruckenstein M J, Milburn M, Hu L. Strial dysfunction in the MRL-Fas mouse. Otolaryngol Head Neck Surg. 1999; 121: 452-456.
5Herman P, Tan CT, van den Abbeele T, et al. Glucocorticosteroids increase sodium transport in middle ear epithelium. Am J Physiol.1997;272(1 pt 1): c184-190.
7Harris JP, Waisman MH, Derebery JM, et al. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.. JAMA. 2003; 290: 1875-1883.
8Champigny G, Voilley N, Lingueglia E, et al. Regulation of expression of the lung amiloride-sensitive Na + channel by steroid hormones. EMBO J. 1994; 13: 2177-2181.
9Trune DR, Kempton JB. Aldosterone and prednisolone control of cochlear function in MRL /MpJ-Fas (lpr) autoimmune mice. Hear Res. 2001; 155: 9-20.
10Kumagami H, Loewenheim H, Beitz E, et al. The effect of anti-diuretic hormone on the endolymphatic sac of the inner ear. Pflugers Arch. 1998; 436: 970-975.
